Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xilio Therapeutics, Inc. | 6,371 | reported | 02 Jan 2026 | tx 20+542,921−113,629 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jan 2026 | EXERCISE | Xilio Therapeutics, Inc. | 5,000 | — | |
| 02 Jan 2026 | SALE | Xilio Therapeutics, Inc. | 1,826 | 0.64 USD | |
| 31 Dec 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 95,221 | 0.00 USD | deriv |
| 01 Jan 2026 | EXERCISE | Xilio Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 131,700 | 0.00 USD | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 55,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 55,000 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 25,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 25,000 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 20,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 20,000 | — | deriv |
| 02 Jan 2025 | SALE | Xilio Therapeutics, Inc. | 1,803 | 0.98 USD | |
| 01 Jan 2025 | EXERCISE | Xilio Therapeutics, Inc. | 5,000 | — | |
| 01 Jan 2025 | EXERCISE | Xilio Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 01 Jan 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 01 Oct 2024 | GRANT_AWARD | Xilio Therapeutics, Inc. | 26,000 | 0.00 USD | deriv |
| 01 May 2024 | GRANT_AWARD | Xilio Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 01 Jan 2024 | GRANT_AWARD | Xilio Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 16 Aug 2023 | GRANT_AWARD | Xilio Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 01 Apr 2023 | GRANT_AWARD | Xilio Therapeutics, Inc. | 55,000 | 0.00 USD | deriv |